Get started
INTECH BIOPHARM LTDINTECH BIOPHARM LTDINTECH BIOPHARM LTD

INTECH BIOPHARM LTD

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

6461 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Intech Biopharm Ltd. engages in the development of drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease. Its products include HFA metered dosage inhaler; respiratory drugs; and oncology drugs. The company was founded on October 28, 2010 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6461 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company